Key facts
- Cercare Medical’s last known valuation is $30.0M (Dec 2021).
- It has raised $18.9M; the latest was PE Growth/Expansion ($7.7M) in Feb 2025.
- Notable investors include European Innovation Council, European Union, Herfo, Bagger-Sørensen Equity, Canica — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Cercare Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Cercare Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cercare Medical
Developer of a medical imaging technology designed to diagnose strokes and cardiac failures. The company's technology offers advanced perfusion analysis for brain tissue status assessment while using artificial intelligence to identify and quantify stroke lessons for patient care, thereby enabling healthcare professionals to provide personalized patient care.
- Sector
- Healthcare
- HQ
- Aarhus, Denmark
- Founded
- 2013
- Employees
- 50
- Website
- cercare-medical.com/
- Ownership
- Privately Held (backing)
Cercare Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cercare Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cercare Medical in its N-PORT filings yet. We sweep new filings monthly.